Diphtheria and tetanus toxoids/pertussis, acellular Interactions
There are 299 drugs known to interact with diphtheria and tetanus toxoids/pertussis, acellular, along with 4 disease interactions. Of the total drug interactions, 1 is major, 295 are moderate, and 3 are minor.
- View all 299 medications that may interact with diphtheria and tetanus toxoids/pertussis, acellular
- View diphtheria and tetanus toxoids/pertussis, acellular disease interactions (4)
Most frequently checked interactions
View interaction reports for diphtheria and tetanus toxoids / pertussis, acellular and the medicines listed below.
- Actos (pioglitazone)
- Albumin-Alpine (albumin human)
- Aldactone (spironolactone)
- Anectine (succinylcholine)
- Antabuse (disulfiram)
- Axid (nizatidine)
- Azithromycin Dose Pack (azithromycin)
- Benadryl Allergy (diphenhydramine)
- Betadine Antibiotic (bacitracin / polymyxin b topical)
- Brevital Sodium (methohexital)
- Cardizem (diltiazem)
- Colace (docusate)
- Colace Micro-Enema (docusate)
- Crestor (rosuvastatin)
- Curcumin 95 (turmeric)
- Cytomel (liothyronine)
- Dilaudid (hydromorphone)
- Flucelvax Quadrivalent (influenza virus vaccine, inactivated)
- GlucaGen (glucagon)
- Glucotrol (glipizide)
- Indocin (indomethacin)
- Integrilin (eptifibatide)
- Librium (chlordiazepoxide)
- Lugol's (iodine / potassium iodide)
- Lupron (leuprolide)
- MethylPREDNISolone Dose Pack (methylprednisolone)
- Motrin (ibuprofen)
- Mutamycin (mitomycin)
- Natrecor (nesiritide)
- Protonix (pantoprazole)
Diphtheria and tetanus toxoids/pertussis, acellular disease interactions
There are 4 disease interactions with diphtheria and tetanus toxoids / pertussis, acellular which include:
Report options
QR code containing a link to this page
More about diphtheria and tetanus toxoids / pertussis, acellular
- diphtheria and tetanus toxoids/pertussis, acellular consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: vaccine combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.